Biomx Inc Financials

PHGE

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Biomx Inc (PHGE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

1/9

Biomx Inc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.73x

For every $1 of reported earnings, Biomx Inc generates $0.73 in operating cash flow (-$26.4M OCF vs -$36.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-2073.3x

Biomx Inc earns $-2073.3 in operating income for every $1 of interest expense (-$41.5M vs $20K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Revenue

N/A

EBITDA

-$38.5M

YoY+9.8%

Biomx Inc's EBITDA was -$38.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.8% from the prior year.

Free Cash Flow

-$26.4M

YoY+28.7%

Biomx Inc generated -$26.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 28.7% from the prior year.

Net Income

-$36.2M

YoY-104.2%

Biomx Inc reported -$36.2M in net income in fiscal year 2025. This represents a decrease of 104.2% from the prior year.

EPS (Diluted)

$22.19

YoY-61.9%

Biomx Inc earned $22.19 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 61.9% from the prior year.

Cash & Debt

$4.4M

YoY-74.1%

5Y CAGR-34.6%

Biomx Inc held $4.4M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+55.8%

Biomx Inc had 2M shares outstanding in fiscal year 2025. This represents an increase of 55.8% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

2780.3%

Biomx Inc's ROE was 2780.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

R&D Spending

$21.3M

YoY-13.7%

5Y CAGR+1.9%

Biomx Inc invested $21.3M in research and development in fiscal year 2025. This represents a decrease of 13.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$2K

YoY-93.3%

5Y CAGR-71.2%

Biomx Inc invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 93.3% from the prior year.

PHGE Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$21.3M-13.7%	$24.7M+47.7%	$16.7M+2.8%	$16.2M-28.4%	$22.7M+16.8%	$19.4M
SG&A Expenses	$9.6M-18.2%	$11.8M+36.1%	$8.7M-8.5%	$9.5M-16.1%	$11.3M+20.9%	$9.3M
Operating Income	-$41.5M+6.9%	-$44.5M-75.6%	-$25.3M+6.9%	-$27.2M+23.2%	-$35.5M-17.2%	-$30.3M
Interest Expense	$20K-97.6%	$850K-64.6%	$2.4M+16.2%	$2.1M+196.0%	$699K	N/A
Income Tax	$7K-46.2%	$13K-43.5%	$23K-64.6%	$65K-3.0%	$67K	N/A
Net Income	-$36.2M-104.2%	-$17.7M+32.3%	-$26.2M+7.6%	-$28.3M+21.8%	-$36.2M-20.4%	-$30.1M
EPS (Diluted)	$22.19-61.9%	$58.31	$5.10	$0.95-31.7%	$1.39	N/A

Metric	Q4'25	Q3'25	Q3'25	Q3'25	Q4'24	Q3'24	Q3'24	Q3'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$6.1M+22.1%	$5.0M-4.5%	$5.3M	N/A	$7.3M+5.5%	$6.9M+68.0%	$4.1M
SG&A Expenses	N/A	$2.4M-0.2%	$2.4M-3.5%	$2.5M	N/A	$3.2M+14.9%	$2.8M+5.5%	$2.7M
Operating Income	N/A	-$8.5M-14.8%	-$7.4M+4.2%	-$7.8M	N/A	-$11.3M-16.5%	-$9.7M-43.3%	-$6.8M
Interest Expense	N/A	$5K0.0%	$5K-99.4%	$850K	N/A	$5K-99.4%	$850K0.0%	$850K
Income Tax	N/A	$3K+50.0%	$2K+100.0%	$1K	N/A	$48K+855.5%	$5K0.0%	$5K
Net Income	N/A	-$9.2M-51.8%	-$6.0M+21.2%	-$7.7M	N/A	$9.6M+115.7%	$4.5M+125.8%	-$17.3M
EPS (Diluted)	N/A	$0.29+52.6%	$0.19-42.4%	$0.33	N/A	$-0.31	$0.69	$2.78

PHGE Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.8M-86.6%	$43.2M+72.7%	$25.0M-45.0%	$45.5M-41.6%	$78.0M+10.8%	$70.4M
Current Assets	$5.6M-72.8%	$20.5M+16.4%	$17.6M-52.2%	$36.9M-44.7%	$66.6M+9.8%	$60.7M
Cash & Equivalents	$4.4M-74.1%	$16.9M+13.1%	$14.9M-52.4%	$31.3M-49.5%	$62.1M+70.2%	$36.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$501-99.9%	$801K	N/A	N/A	N/A	N/A
Total Liabilities	$7.1M-62.9%	$19.1M-13.0%	$21.9M-10.4%	$24.5M-19.6%	$30.5M+136.2%	$12.9M
Current Liabilities	$6.4M-22.8%	$8.3M-26.0%	$11.2M+40.8%	$7.9M-28.1%	$11.0M+54.2%	$7.2M
Long-Term Debt	N/A	N/A	$5.4M-49.0%	$10.6M-26.5%	$14.4M+186.4%	$5.0M
Total Equity	-$1.3M-105.4%	$24.1M+683.8%	$3.1M-85.4%	$21.0M-55.7%	$47.5M-17.3%	$57.5M
Retained Earnings	-$216.9M-20.0%	-$180.7M-10.9%	-$163.0M-19.1%	-$136.8M	N/A	N/A

Metric	Q4'25	Q3'25	Q3'25	Q3'25	Q4'24	Q3'24	Q3'24	Q3'24
Total Assets	$5.8M-77.9%	$26.2M-31.2%	$38.0M-16.7%	$45.7M+5.6%	$43.2M-27.9%	$60.0M-12.6%	$68.6M-15.9%	$81.6M
Current Assets	$5.6M-37.1%	$8.9M-46.7%	$16.6M-29.3%	$23.5M+14.7%	$20.5M-27.5%	$28.3M-19.3%	$35.1M-25.5%	$47.1M
Cash & Equivalents	$4.4M-37.0%	$6.9M-50.7%	$14.0M-30.2%	$20.1M+19.3%	$16.9M-28.4%	$23.5M-25.5%	$31.6M-26.5%	$43.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	$801K0.0%	$801K-94.9%	$15.8M0.0%	$15.8M
Total Liabilities	$7.1M-54.8%	$15.7M-17.0%	$18.9M-10.7%	$21.2M+10.8%	$19.1M-13.6%	$22.1M-46.4%	$41.2M-54.8%	$91.2M
Current Liabilities	$6.4M+22.1%	$5.2M-16.5%	$6.3M-10.8%	$7.0M-15.1%	$8.3M-7.6%	$8.9M+22.4%	$7.3M-31.8%	$10.7M
Long-Term Debt	N/A	N/A	N/A	N/A	$856K	N/A	N/A	N/A
Total Equity	-$1.3M-112.4%	$10.5M-45.3%	$19.2M-21.8%	$24.5M+1.5%	$24.1M-36.3%	$37.9M+38.2%	$27.4M+387.4%	-$9.5M
Retained Earnings	-$216.9M-6.6%	-$203.6M-4.7%	-$194.4M-3.2%	-$188.4M-4.2%	-$180.7M-8.7%	-$166.2M+5.5%	-$175.8M+2.5%	-$180.3M

PHGE Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$26.4M+28.6%	-$37.0M-73.7%	-$21.3M+26.8%	-$29.1M-5.5%	-$27.6M-12.8%	-$24.4M
Capital Expenditures	$2K-93.3%	$30K-40.0%	$50K-55.4%	$112K-97.0%	$3.7M+264.9%	$1.0M
Free Cash Flow	-$26.4M+28.7%	-$37.0M-73.5%	-$21.3M+26.9%	-$29.2M+6.6%	-$31.3M-22.8%	-$25.5M
Investing Cash Flow	$108K-84.9%	$715K-63.4%	$2.0M+192.6%	-$2.1M-113.0%	$16.2M+249.0%	-$10.9M
Financing Cash Flow	$13.2M-65.6%	$38.4M+1223.7%	$2.9M+892.8%	$292K-99.2%	$37.3M+27720.9%	$134K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q3'25	Q3'25	Q4'24	Q3'24	Q3'24	Q3'24
Operating Cash Flow	-$4.4M+38.9%	-$7.2M-17.6%	-$6.1M+29.9%	-$8.7M-38.5%	-$6.3M+22.3%	-$8.1M+27.9%	-$11.2M+1.0%	-$11.4M
Capital Expenditures	$0	N/A	N/A	N/A	$11K+10.0%	$10K-98.4%	$629K+359.1%	$137K
Free Cash Flow	-$4.4M	N/A	N/A	N/A	-$6.3M+22.3%	-$8.1M-130.5%	-$3.5M-10.7%	-$3.2M
Investing Cash Flow	$1K+150.0%	-$2K-103.4%	$58K+13.7%	$51K+5200.0%	-$1K0.0%	-$1K-101.9%	$54K-91.9%	$663K
Financing Cash Flow	$1.3M+2216.7%	$54K+286.2%	-$29K-100.2%	$11.9M+3093.2%	-$398K	$0+100.0%	-$203K-100.5%	$39.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

PHGE Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	2780.3%	N/A	N/A	N/A	N/A	N/A
Return on Assets	-626.0%-585.0pp	-41.0%+63.6pp	-104.6%-42.4pp	-62.2%-15.7pp	-46.5%-3.7pp	-42.8%
Current Ratio	0.87-1.6	2.48+0.9	1.58-3.1	4.65-1.4	6.03-2.4	8.47
Debt-to-Equity	-5.44-6.2	0.79-1.0	1.75+1.2	0.50+0.2	0.30+0.2	0.09
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q3'25	Q3'25	Q4'24	Q3'24	Q3'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	25.4%+9.1pp	16.3%	N/A
Return on Assets	N/A	-35.0%-19.2pp	-15.9%+0.9pp	-16.8%	N/A	16.1%+9.6pp	6.5%+27.7pp	-21.2%
Current Ratio	0.87-0.8	1.70-1.0	2.66-0.7	3.35+0.9	2.48-0.7	3.17-1.6	4.80+0.4	4.40
Debt-to-Equity	-5.44-6.9	1.50+0.5	0.99+0.1	0.86+0.1	0.79+0.2	0.58-0.9	1.50+11.1	-9.55
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Phio Pharmaceuticals Corp PHIO

$11.1M

Adaptimmune Therapeutics Plc ADAP

$14.6M

Biovie Inc BIVI

$9.5M

APOLLOMICS INC APLM

$42.7M

Aptorum Group Ltd APM

$6.4M

Frequently Asked Questions

Is Biomx Inc profitable?

No, Biomx Inc (PHGE) reported a net income of -$36.2M in fiscal year 2025.

What is Biomx Inc's earnings per share (EPS)?

Biomx Inc (PHGE) reported diluted earnings per share of $22.19 for fiscal year 2025. This represents a -61.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Biomx Inc's EBITDA?

Biomx Inc (PHGE) had EBITDA of -$38.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Biomx Inc's return on equity (ROE)?

Biomx Inc (PHGE) has a return on equity of 2780.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Biomx Inc's free cash flow?

Biomx Inc (PHGE) generated -$26.4M in free cash flow during fiscal year 2025. This represents a 28.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Biomx Inc's operating cash flow?

Biomx Inc (PHGE) generated -$26.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Biomx Inc's total assets?

Biomx Inc (PHGE) had $5.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Biomx Inc's capital expenditures?

Biomx Inc (PHGE) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Biomx Inc spend on research and development?

Biomx Inc (PHGE) invested $21.3M in research and development during fiscal year 2025.

How many shares does Biomx Inc have outstanding?

Biomx Inc (PHGE) had 2M shares outstanding as of fiscal year 2025.

What is Biomx Inc's current ratio?

Biomx Inc (PHGE) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Biomx Inc's debt-to-equity ratio?

Biomx Inc (PHGE) had a debt-to-equity ratio of -5.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Biomx Inc's return on assets (ROA)?

Biomx Inc (PHGE) had a return on assets of -626.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Biomx Inc's cash runway?

Based on fiscal year 2025 data, Biomx Inc (PHGE) had $4.4M in cash against an annual operating cash burn of $26.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Biomx Inc's debt-to-equity ratio negative or unusual?

Biomx Inc (PHGE) has negative shareholder equity of -$1.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Biomx Inc's Piotroski F-Score?

Biomx Inc (PHGE) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Biomx Inc's earnings high quality?

Biomx Inc (PHGE) has an earnings quality ratio of 0.73x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Biomx Inc cover its interest payments?

Biomx Inc (PHGE) has an interest coverage ratio of -2073.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.